NE LB 252
deadProhibit disadvantaging insurance and Medicaid coverage for nonopioid drugs
Nebraska · 2026 Regular Session (109th Legislature, 2nd Session) · legislature
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did NE LB 252 pass?
No. NE LB 252 did not pass — it was defeated or died in the legislative process. Latest recorded action (2026-04-17): Indefinitely postponed
What is NE LB 252 about?
NE LB 252 is a bill in the 2026 Regular Session (109th Legislature, 2nd Session) titled “Prohibit disadvantaging insurance and Medicaid coverage for nonopioid drugs”.
Who sponsors NE LB 252?
Bostar is the primary sponsor of NE LB 252.
- Introduced
- 2025-01-14
- Latest action
- 2026-04-17 — Indefinitely postponed
- Bill type
- bill
- Last updated
- —
Sponsors
- Bostarprimary
Committees
Not provided by source.
Action timeline
Newest first
2026-04-17
Indefinitely postponed
committee-failure
2026-01-07
Title printed. Carryover bill
2025-01-30
Notice of hearing for February 24, 2025
2025-01-16
Referred to Banking, Commerce and Insurance Committee
referral-committee
2025-01-14
Date of introduction
introduction
Versions
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:27:15.448898Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NE&identifier=LB 252. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.